Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort

English version České info

In a retrospective cohort study, Bethan Davies and colleagues estimate the impact of non-NAAT testing on risk of subsequently developing pelvic inflammatory disease.

Vyšlo v časopise: Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort. PLoS Med 15(1): e32767. doi:10.1371/journal.pmed.1002483
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002483

Souhrn

In a retrospective cohort study, Bethan Davies and colleagues estimate the impact of non-NAAT testing on risk of subsequently developing pelvic inflammatory disease.

Zdroje

1. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS ONE. 2015;10(12):e0143304. doi: 10.1371/journal.pone.0143304 26646541; PubMed Central PMCID: PMC4672879.

2. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235–e79. Epub 2017/07/14. doi: 10.1016/S1473-3099(17)30310-9 28701272.

3. European Centre for Disease Prevention and Control. Chlamydia control in Europe: a survey of Member States 2012. Stockholm ECDC, 2014 February 2014. Report No.

4. Schachter J. Rapid diagnosis of sexually transmitted diseases—speed has a price. Diagnostic microbiology and infectious disease. 1986;4(3):185–9. Epub 1986/03/01. 3082583.

5. Chernesky MA. The laboratory diagnosis of Chlamydia trachomatis infections. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale / AMMI Canada. 2005;16(1):39–44. Epub 2007/12/27. 18159527; PubMed Central PMCID: PMCPmc2095010.

6. Newhall WJ, Johnson RE, DeLisle S, Fine D, Hadgu A, Matsuda B, et al. Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standard. J Clin Microbiol. 1999;37(3):681–5. Epub 1999/02/13. 9986831; PubMed Central PMCID: PMC84517.

7. British Association for Sexual Health and HIV. 2006 UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis. 2006.

8. Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. International journal of STD & AIDS. 2016;27(5):333–48. Epub 2015/11/27. doi: 10.1177/0956462415618837 26608577.

9. World Health Organisation. WHO Guidelines for the treatment of Chlamydia trachomatis. Geneva, Switzerland: WHO, 2016 ISBN 978 92 4 154971 4.

10. Adachi K, Nielsen-Saines K, Klausner JD. Chlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and Asia. BioMed Research International. 2016;2016 : 21. doi: 10.1155/2016/9315757 27144177

11. Cliffe SJ, Tabrizi S, Sullivan EA. Chlamydia in the Pacific region, the silent epidemic. Sexually transmitted diseases. 2008;35(9):801–6. Epub 2008/06/27. doi: 10.1097/OLQ.0b013e318175d885 18580823.

12. Otieno FO, Ndivo R, Oswago S, Ondiek J, Pals S, McLellan-Lemal E, et al. Evaluation of syndromic management of sexually transmitted infections within the Kisumu Incidence Cohort Study. International journal of STD & AIDS. 2014;25(12):851–9. doi: 10.1177/0956462414523260. 24516075

13. World Health Organisation. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: WHO, 2003 ISBN 92 4 154626 3.

14. Davies B, Turner KM, Frolund M, Ward H, May MT, Rasmussen S, et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis. 2016;16(9):1057–64. doi: 10.1016/S1473-3099(16)30092-5 27289389.

15. Statbank Denmark. Population 1. January by sex, age and time: Statistics Denmark 2017 [cited 2017 17.10.17]. Available from: http://www.statistikbanken.dk/statbank5a/default.asp?w=1920.

16. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scandinavian journal of public health. 2011;39(7 Suppl):30–3. doi: 10.1177/1403494811401482 21775347.

17. Public Health England. Health Protection Report: weekly report. PHE, 2015 23 June 2015. Report No.: Contract No.: 22.

18. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340(20378636).

19. Davies B, Turner KM, Leung S, Yu BN, Frolund M, Benfield T, et al. Comparison of the population excess fraction of Chlamydia trachomatis infection on pelvic inflammatory disease at 12-months in the presence and absence of chlamydia testing and treatment: Systematic review and retrospective cohort analysis. PLoS ONE. 2017;12(2):e0171551. doi: 10.1371/journal.pone.0171551 28199392.

20. Hadgu A, Sternberg M. Reproducibility and specificity concerns associated with nucleic acid amplification tests for detecting Chlamydia trachomatis. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2009;28(1):9–15. doi: 10.1007/s10096-008-0586-3 18642036.

21. Statistics Denmark FOLK1A: POPULATION AT THE FIRST DAY OF THE QUARTER BY REGION, SEX, AGE AND MARITAL STATUS 2017 [cited 2017 13 July 2017]. Available from: http://www.statbank.dk/statbank5a/default.asp?w=1600.

22. Price MJ, Ades AE, Angelis DD, Welton NJ, Macleod J, Soldan K, et al. Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Statistics in medicine. 2013;32(9):1547–60. Epub 2012/09/06. doi: 10.1002/sim.5603 22949217.

23. Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sexually transmitted diseases. 2013;40(2):97–102. doi: 10.1097/OLQ.0b013e31827bd637 23324973.